A Clinical Trial to Evaluate the Efficacy and Safety of Two Aramchol Doses Versus Placebo in Patients With NASH

Clinical trial NCT02279524 · COMPLETED

Trial details

NCT number: NCT02279524
Sponsor: Galmed Research and Development, Ltd.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Fatty Liver Non-Alcoholic Steatohepatitis Liver Diseases Liver Fibroses

Start date: 2015-04-29
Primary completion: 2018-05-22
Enrollment: 247

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.